Tissue Repair Ltd (ASX:TRP)
Australia · Delayed Price · Currency is AUD 0.0820
0.00 (0.00%)
Sep 18, 2026, 3:28 PM AEST
Tissue Repair Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 0.56 | 0.42 | 0.15 | 0 | - |
Other Revenue | 2.43 | 2.21 | 1.64 | 0.97 | 0.17 |
| 2.99 | 2.63 | 1.79 | 0.97 | 0.17 | |
Revenue Growth | 13.58% | 47.04% | 84.31% | 465.17% | 12.63% |
Cost of Revenue | 0.22 | - | - | - | - |
Gross Profit | 2.77 | 2.63 | 1.79 | 0.97 | 0.17 |
Selling, General & Admin | 3 | 3.2 | 3.13 | 2.42 | 1.95 |
Research & Development | 4.86 | 4.04 | 3.24 | 2.61 | 1.42 |
Operating Expenses | 8.31 | 7.46 | 6.67 | 5.74 | 4.23 |
Operating Income | -5.54 | -4.83 | -4.88 | -4.77 | -4.05 |
Interest Expense | - | - | - | - | -0 |
Interest & Investment Income | 0.21 | 0.38 | 0.74 | 0.43 | 0.04 |
Currency Exchange Gain (Loss) | -0.03 | 0.2 | -0 | 0.17 | 0.27 |
Other Non Operating Income (Expenses) | - | - | - | - | -1.22 |
EBT Excluding Unusual Items | -5.36 | -4.24 | -4.14 | -4.17 | -4.96 |
Other Unusual Items | - | - | - | - | -1.88 |
Pretax Income | -5.36 | -4.24 | -4.14 | -4.17 | -6.84 |
Net Income | -5.36 | -4.24 | -4.14 | -4.17 | -6.84 |
Net Income to Common | -5.36 | -4.24 | -4.14 | -4.17 | -6.84 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 50 |
Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 50 |
Shares Change | - | - | - | 21.50% | 202.95% |
EPS (Basic) | -0.09 | -0.07 | -0.07 | -0.07 | -0.14 |
EPS (Diluted) | -0.09 | -0.07 | -0.07 | -0.07 | -0.14 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -7.55 | -4.12 | -4.95 | -4.26 | -3.97 |
Free Cash Flow Per Share | -0.13 | -0.07 | -0.08 | -0.07 | -0.08 |
Gross Margin | 92.50% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -185.40% | -183.24% | -272.37% | -491.09% | -2357.84% |
Profit Margin | -179.28% | -160.96% | -231.07% | -429.62% | -3977.17% |
Free Cash Flow Margin | -252.36% | -156.49% | -276.66% | -438.19% | -2309.24% |
EBITDA | -5.32 | -4.72 | -4.88 | -4.77 | -4.05 |
EBITDA Margin | -177.95% | -179.30% | -272.27% | - | - |
D&A For EBITDA | 0.22 | 0.1 | 0 | 0 | 0 |
EBIT | -5.54 | -4.83 | -4.88 | -4.77 | -4.05 |
EBIT Margin | -185.40% | -183.24% | -272.37% | - | - |
Revenue as Reported | 3.21 | 3.22 | 2.53 | 1.57 | 0.49 |
Advertising Expenses | 0.15 | 0.88 | 0.27 | 0.09 | - |